Lauric Acid
(Synonyms: 月桂酸) 目录号 : GC15993
A medium-chain fatty acid
Cas No.:143-07-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Lauric acid, a saturated medium-chain fatty acid with a 12-carbon backbone, is naturally found in various plant and animal fats and oils, which is a major component of palm kernel oil and coconut oil.
In vitro: Previous study showed that lauric acid could induce apoptosis in both Caco-2 and IEC-6 cells when compared to butyrate. Moreover, lauric acid reduced GSH availability and generated ROS in Caco-2 cells. Mechanistic study indicated that lauric acid reduced Caco-2 and IEC-6 cells in G0/G1and arrested cells in the S and G2/M phases. In addition, it was found that butyrate protected IEC-6 cells from ROS-induced damage, while lauric acid induced higher levels of ROS when compared with butyrate [1].
In vivo: Mouse in vivo study found that both epicutaneous application and intradermal injection of lauric acid could decrease the number of P. acnes colonized in mouse ears effectively, thus relieving P. acnes-induced granulomatous inflammation and ear swelling [2].
Clinical trial: Previous clinical study showed that lauric acid ingestion did not induce nausea or bloating. There was no effect of lauric acid on energy intake at breakfast, energy intake at lunch was reduced significantly after ingestion of lauric acid. In addition, it was observed that the total energy intake (breakfast+lunch+lauric acid dose) was less following ingestion of 6 g of lauric acid compared with control [3].
References:
[1] Fauser JK,Matthews GM,Cummins AG,Howarth GS. Induction of apoptosis by the medium-chain length fatty acid lauric acid in colon cancer cells due to induction of oxidative stress. Chemotherapy.2013;59(3):214-24.
[2] Nakatsuji T,Kao MC,Fang JY,Zouboulis CC,Zhang L,Gallo RL,Huang CM. Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris. J Invest Dermatol.2009 Oct;129(10):2480-8.
[3] Kate L. Feltrin et al. Acute oral administration of lauric acid reduces energy intake in healthy males. e-SPEN Journal. 2014 April; 9 (2): e69–e75
| Cas No. | 143-07-7 | SDF | |
| 别名 | 月桂酸 | ||
| 化学名 | dodecanoic acid | ||
| Canonical SMILES | CCCCCCCCCCCC(O)=O | ||
| 分子式 | C12H24O2 | 分子量 | 200.32 |
| 溶解度 | ≥ 40.2 mg/mL in DMSO, ≥ 40.4 mg/mL in EtOH | 储存条件 | 4°C, protect from light |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 4.992 mL | 24.9601 mL | 49.9201 mL |
| 5 mM | 0.9984 mL | 4.992 mL | 9.984 mL |
| 10 mM | 0.4992 mL | 2.496 mL | 4.992 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet